MitoQ, the first antioxidant formula able to penetrate mitochondria and deliver antioxidants at meaningful levels, has been selected for an internationally renowned anti-aging test known as the Intervention Testing Program (ITP) and run by the National Institute on Aging (NIA), a branch of the U.S. National Institutes of Health.
MitoQ is a synthetic antioxidant, analogous to the natural antioxidant Coenzyme Q10 (CoQ10) that accumulates within the mitochondria and is able to efficiently reduce oxidative stress, minimizing the damage to cells. It was developed by MitoQ, Ltd., a subsidiary of Antipodean Pharmaceuticals, Inc., headquartered in New Zealand.
“Selection for the program validates a widening view within the research community that MitoQ confers anti-aging benefits by delivering the body’s natural antioxidant CoQ10 to mitochondria, optimizing mitochondria and its benefits. Until now, other sources of CoQ10 were unable to infiltrate the mitochondria and thus make a tangible difference,” said Greg Macpherson, the company’s chief executive officer.
“Research has shown that aging, and its associated health issues and lower energy levels, is linked to a decline in mitochondrial function. Mitochondria, our ‘cellular batteries’, are present in almost every cell in the body. Flooding the mitochondria with antioxidants improves the level of energy available to a cell and reduces free radical-associated cell damage. By improving their function while reducing cell damage, we may slow down the aging process keeping all of our organs and body healthier and younger for longer,” Macpherson added.
The CEO also noted that “MitoQ was chosen for the testing program because it shows significant potential to delay or decelerate the aging process and improve general health.”
The results of the ITP clinical trial will be made available in 2020 and are expected to be featured in several scientific journals, including Nature, Journals of Gerontology and Aging Cell.
Learn more about MitoQ’s action on mitochondria by watching the video below: